摘要
Abstract
Objective To analyze the clinical treatment of advanced non-small cell lung cancer in the application for it's clinical curative effect, adverse reaction and so on. Methods from April 2009 to April 2009 in patients with advanced non-small cell lung cancer treated during selecting 30 cases as the research object, and to give patients used it for treatment,if patients lesions appears on the horizon,can't tolerate the side reaction of,end treatment,after the application of the drug were observed during the period of efficacy,adverse reaction,etc. Results The study found that 30 cases of advanced non-small cell lung cancer patients,11 patients with disease progression (PD),12 patients had stable disease (SD),7 cases of patients with partial response (PR),and 0 cases with complete remission (CR),effective treatment cases in 7 cases,accounting for 23.33% of the total. In terms of adverse reactions,patients after medication,there are mainly nausea and vomiting,diarrhea,itching and rash,etc.,were serious degree,through the appropriate ease after treatment. Conclusion In the clinical treatment of patients with advanced non-small cell lung cancer in the application,for it has obvious curative effect,and side reaction was mild.关键词
厄洛替尼/晚期非小细胞肺癌/疗效/毒副反应Key words
Erlotinib/Advanced non-small cell lung cancer/Curative effect/Adverse reaction分类
医药卫生
